Market Tracker

01/20 5:16pm ET

Celgene Corp (NASDAQ:CELG)

112.66
Delayed Data
As of Jan 20
 -0.96 / -0.84%
Today’s Change
93.05
Today|||52-Week Range
127.00
-2.67%
Year-to-Date

Today’s Trading

Previous close113.62
Today’s open114.28
Day’s range112.42 - 114.75
Volume5,288,587
Average volume (3 months)4,571,819
Market cap$87.3B
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-18.83%
Earnings growth (this year)+25.78%
Earnings growth (next 5 years)+21.18%
Revenue growth (last year)+16.47%
P/E ratio42.8
Price/Sales11.10
Price/Book14.97

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co-0.03-0.04%
BMYBristol-Myers Squibb-6.26-11.28%
AGNAllergan-0.24-0.11%
GSKGlaxoSmithKline-0.03-0.08%
Data as of 4:01pm ET, 01/20/2017

Financials

Next reporting dateJanuary 26, 2017
EPS forecast (this quarter)$1.59
Annual revenue (last year)$8.9B
Annual profit (last year)$1.6B
Net profit margin18.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President, Chief Operating Officer &
Director
Jacqualyn A. Fouse
Corporate headquarters
Summit, New Jersey

Forecasts